Posted by Michael Wonder on 14 Apr 2022
ICER publishes 2022 research protocol for assessing unsupported price increases on prescription drugs
14 April 2022 - Final assessment to be published on 6 December 2022.
The ICER today posted a protocol outlining how we will conduct our next analysis of “Unsupported Price Increases” among prescription drugs within the US market.
This initiative will identify the 10 net price increases occurring in 2021 that had the largest impact on national drug spending and determine whether new clinical evidence existed that could support those price increases.
This year, for the first time, the initiative will also evaluate whether new evidence existed to support the three highest list price increases in 2020 for drugs primarily covered through Medicare Part B.
